Sign in

CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company

ATOSSA THERAPEUTICS, INC.

Sign in to watch
Ticker
ATOS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
264753208
Phone
206.588.0256
Business address
1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
Former names
ATOSSA GENETICS INC
  1. 4 Open-market buy Director bought 10,000 shares at $2.58 ($25,785)
  2. 4 Grant or award Director acquired 24,510 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale CEO sold 7,265 shares at $5.66 ($41,105)
  5. 4 Open-market sale Chief Scientific Officer sold 7,265 shares at $5.66 ($41,105)
  6. 4 Open-market buy Director bought 500 shares at $5.49 ($2,745)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy Director bought 4,000 shares at an average $4.12 ($16,460)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 8 of 9 · 161 filings